{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/immuno-oncology-publication-spotlight-our-top-recent-peer-reviewed-journal-articles#webpage",
"url": "https://www.fortrea.com/insights/immuno-oncology-publication-spotlight-our-top-recent-peer-reviewed-journal-articles",
"name": "Immuno-oncology publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing immuno-oncology drug development",
"description": "Explore how immuno-oncology drug development is advancing through peer-reviewed oncology research and scientific publications that contribute to cancer immunotherapy innovation. Learn how clinical trial publications in oncology highlight translational immuno-oncology research, providing insights into novel therapies, biomarkers, and evolving treatment strategies. Explore how immuno-oncology journal articles authored by leading experts support evidence generation, scientific collaboration, and informed decision-making in clinical development. Learn how advancing oncology research publications strengthen research expertise and accelerate progress across immuno-oncology drug development. By integrating peer-reviewed evidence with clinical and translational research, organizations can drive more effective and innovative cancer treatment development."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Immuno-oncology publication spotlight: our top recent peer-reviewed journal articles featuring Fortrea oncologists discussing immuno-oncology drug development",
"item": "https://www.fortrea.com/insights/immuno-oncology-publication-spotlight-our-top-recent-peer-reviewed-journal-articles"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry - as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/immuno-oncology-publication-spotlight-our-top-recent-peer-reviewed-journal-articles#article",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/immuno-oncology-publication-spotlight-our-top-recent-peer-reviewed-journal-articles#webpage"
},
"headline": "Immuno-Oncology Drug Development and Peer-Reviewed Oncology Research Publications | Fortrea Insights",
"description": "Explore how immuno-oncology drug development is advancing through peer-reviewed oncology research and scientific publications that contribute to cancer immunotherapy innovation. Learn how clinical trial publications in oncology highlight translational immuno-oncology research, providing insights into novel therapies, biomarkers, and evolving treatment strategies. Explore how immuno-oncology journal articles authored by leading experts support evidence generation, scientific collaboration, and informed decision-making in clinical development. Learn how advancing oncology research publications strengthen research expertise and accelerate progress across immuno-oncology drug development. By integrating peer-reviewed evidence with clinical and translational research, organizations can drive more effective and innovative cancer treatment development.",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/immuno-oncology-publication-spotlight.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-19",
"dateModified": "2025-03-19",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-07/immuno-oncology-publication-spotlight-fortrea-oncologists.pdf",
"encodingFormat": "application/pdf"
}
}
]
}